Financial News
Latest News about AMGN
Recent news which mentions AMGN
Is Now the Time to Invest in the Dow Jones?
February 28, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
From Benzinga
Why Turning Point Is Turning Heads
February 23, 2021
From Motley Fool
2 Best Pharma Stocks to Buy Right Now
February 23, 2021
From Motley Fool
From Benzinga
3 Biotech Stocks to Buy As Things Heat Up for the Sector
February 18, 2021
From InvestorPlace
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
3 Dividend Stocks for Market-Beating Yields and High Growth
February 05, 2021
From InvestorPlace
How Bristol Myers Squibb's Celgene Buyout Continued to Pay Off in Q4
February 04, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision
February 03, 2021
From Benzinga
2 Growth Stocks for In-the-Know Investors
February 03, 2021
From Motley Fool
Why Amgen's Q4 Earnings Beat Didn't Impress Investors
February 03, 2021
Tickers
AMGN
From Motley Fool
Amgen posts mixed results, cites COVID-19 impact
February 02, 2021
Tickers
AMGN
Tags
AMGN
From MarketWatch
7 Stocks to Buy for the Long Run
February 02, 2021
From InvestorPlace
The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment
February 02, 2021
From Benzinga
Earnings Scheduled For February 2, 2021
February 02, 2021
From Benzinga
Time for more record earnings reports from Big Tech, led by Amazon’s first $100 billion quarter
February 01, 2021
From MarketWatch
Why Cardiff Oncology Ran Up 1,350% in 2020
January 31, 2021
From Motley Fool
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More
January 30, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
January 29, 2021
From Benzinga
How to Ride the Covid-19 Bull with Moderna
January 28, 2021
From InvestorPlace
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
January 28, 2021
From Benzinga
Here's Why Amazon Will Never Be a Dow Jones Industrials Stock
January 28, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
